Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Sida 1 från 171 resultat
Vomiting and painful abdomen in dementia.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
The two most common causes of dementia in the elderly are Alzheimer's disease (AD) and vascular dementia (VaD), which can coexist as mixed dementia. The object of this study was to assess the efficacy and safety of rivastigmine in patients with mixed dementia (AD with VaD).
METHODS
This
The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Inhibition of acetylcholinesterase improves symptoms of dementia in patients with Parkinson's disease (PD). Dementia in PD has a cumulative incidence of up to 80% and is mainly caused by a distinct cholinergic deficit. Objectives of this investigator initiated multicenter open label trial were to
Eighty-nine-year-old woman with abdominal pain and vomiting.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
UNASSIGNED
An 89-year-old female patient presented to the ED with mild abdominal pain and a history of vomiting for 3 days. Because of dementia, further history was unclear. Vital signs were normal. Clinical examination revealed mild abdominal pain without defence or signs of peritonism. Bowel
Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The objective is to evaluate the efficacy of galantamine when a slow titration regimen is employed in Thai Alzheimer's disease (AD) patients with or without cerebrovascular disease and vascular dementia (VaD). A 6-month, multicentre, open-label, uncontrolled trial was undertaken in 75 AD patients.
[A case of ileus caused by a fecalith in an elderly patient with severe dementia].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
An 82-year-old woman with severe dementia, living in a nursing home, had severe chronic constipation, possibly due to the presence of multiple risk factors for constipation such as a past history of abdominal open surgery, diabetes, hypothyroidism, and bedridden status. She visited our department
Cholinesterase inhibitors for Parkinson's disease dementia.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
The loss of cholinergic, dopaminergic and noradrenergic innervations seen in Parkinson's Disease Dementia (PDD) suggest a potential role for cholinesterase inhibitors. Concerns have been expressed about a theoretical worsening of Parkinson's disease related symptoms particularly movement
Familial neuropathy with dementia, retinitis pigmentosa, and dysautonomia.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
We studied a 59-year-old woman with dementia, retinitis pigmentosa, sensorimotor neuropathy, and attacks of vomiting associated with blood pressure lability and loss of consciousness. Abnormalities included CT evidence of cerebral atrophy, low IQ, slow central and peripheral nerve conduction
[Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
RATIONALE IN ALZHEIMER'S DISEASE: Selective serotonine uptake inhibitors (SSRI) have demonstrated their effectiveness for symptomatic treatment of depression, as well as for behavioral and psychological disorders in dementia patients, particularly in Alzheimer's disease.
UNASSIGNED
SSRI are
Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
There is a global and continuing increase in the population of elderly people. This is particularly true among patients with cancer including those receiving chemotherapy. There are no guidelines that in particular address prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in the
Discovery and optimization of α-mangostin derivatives as novel PDE4 inhibitors for the treatment of vascular dementia.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
To validate PDE4 inhibitors as novel therapeutic agents against vascular dementia (VaD), twenty-five derivatives were discovered from the natural inhibitor α-mangostin (IC50＝1.31 μM). Hit-to-lead optimization identified a novel and selective PDE4 inhibitor 4e (IC50 = 17
[A 85-year-old woman with one year history of convulsion, dementia, and consciousness disturbance].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
We report a 85-year-old woman who died after one year history of convulsion, dementia, and consciousness disturbance. She was apparently well until January 6, 1995 when she was 85 year old; on that evening, she suddenly stated that some one was in her room and she became confused. A local MD gave
A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Rivastigmine patch is the first transdermal treatment to be approved for Alzheimer's disease (AD) and Parkinson's disease dementia in the USA and for AD in Europe. It provides smooth, continuous drug delivery, and has the potential to maintain rivastigmine concentrations within an optimal
Clinical experience of galantamine in dementia: a series of case reports.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To use case studies to add the benefit of personal experience with galantamine to published literature and to demonstrate the type of patients that may benefit from this treatment.
METHODS
We describe eleven patients, aged 57-90 years, fulfilling the consensus diagnostic criteria for
[Adverse events causing discontinuation of donepezil for Alzheimer's dementia].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
The objective was to investigate the frequency of adverse events (AE) as a cause for discontinuation of donepezil treatment for Alzheimer's dementia (DAT) in a geriatric memory unit.
METHODS
Five-year retrospective study of 123 donepezil-treated patients diagnosed with DAT or mixed
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
